<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CDD0F60B-FB27-4CAF-8F9C-AF2F651A372A"><gtr:id>CDD0F60B-FB27-4CAF-8F9C-AF2F651A372A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Conway</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081993"><gtr:id>04B4667B-8811-4B26-AB37-888327F70EA0</gtr:id><gtr:title>Investigating mechanisms of protective immunity against malaria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081993</gtr:grantReference><gtr:abstractText>This project will investigate why some people when infected by the malaria parasite are more likely to develop severe and some are likely to develop mild malaria. Studies addressing this question in that past have led to important developments in scientific understanding of the disease which point to novel treatments and strategies for disease prevention by vaccination. Current therapies and prophylaxis are limited in efficacy so new therapeutic interventions are urgently needed to respond to this increasing threat to health worldwide.</gtr:abstractText><gtr:technicalSummary>A quarter of the risk of severe malaria is determined by host genetic factors, and discovering the genes responsible may provide vital clues about mechanisms of protective immunity and how to develop an effective vaccine. Advances in human genome research provide unprecedented opportunities to identify malaria resistance genes in a systematic and comprehensive manner.This proposal builds on a programme of investigation that has been going on in The Gambia since 1997, which has generated DNA and clinical data from over 2000 children with severe malaria, together with parents of 1500 of these children.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>185594</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Schools visits - Fajara</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>4272D893-252B-40F3-828C-B37EB4E6FB63</gtr:id><gtr:impact>Demonstrations of research on various aspects of malaria by members of the team for high school children

Very positive and good understanding and appreciation of medical research among those in the community</gtr:impact><gtr:outcomeId>C1A8607ABEE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CC161D3D-4123-4D30-B175-90B4B9FDEB10</gtr:id><gtr:title>HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9220bd722f843e0dac27ddc9068ac50c"><gtr:id>9220bd722f843e0dac27ddc9068ac50c</gtr:id><gtr:otherNames>Walther M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14853_23_22438807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C12C07D2-904F-4300-BDC0-FB226FF3E1A7</gtr:id><gtr:title>Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/522e3401574cd4c13fb6eea59f5f9167"><gtr:id>522e3401574cd4c13fb6eea59f5f9167</gtr:id><gtr:otherNames>Osier FH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>ACAC515B776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>849F661F-A4EC-46DA-A2A5-F6C04D35C087</gtr:id><gtr:title>Prospective identification of malaria parasite genes under balancing selection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb6ae59082e81b71e6736b38e1eb96ba"><gtr:id>eb6ae59082e81b71e6736b38e1eb96ba</gtr:id><gtr:otherNames>Tetteh KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5BAAAEFB3DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>267EC987-CA80-4395-BB54-31DD7853033A</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>2BE5119F514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60A329DC-34F2-4ACE-B609-49A1F408E40F</gtr:id><gtr:title>The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc96bd3ad806f00ea29e3bc4e5db2b91"><gtr:id>cc96bd3ad806f00ea29e3bc4e5db2b91</gtr:id><gtr:otherNames>Nogaro SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Sw5AZceQWLW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96CCBFF7-BD3A-49D8-AE31-F214AEB80425</gtr:id><gtr:title>Profiling the antibody immune response against blood stage malaria vaccine candidates.</gtr:title><gtr:parentPublicationTitle>Clinical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81e106960bee9f725a31925e2ea659b9"><gtr:id>81e106960bee9f725a31925e2ea659b9</gtr:id><gtr:otherNames>Gray JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-9147</gtr:issn><gtr:outcomeId>76A337C0B9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25279CA9-0E9B-4FAC-AE9E-8DAC8EA51E3A</gtr:id><gtr:title>Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9220bd722f843e0dac27ddc9068ac50c"><gtr:id>9220bd722f843e0dac27ddc9068ac50c</gtr:id><gtr:otherNames>Walther M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>DAFC17A3CDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8E9A0FF-304D-4FFF-B7AE-5D7227394E29</gtr:id><gtr:title>Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7aa4928325d0f6bca0fac16e8cbf4fcf"><gtr:id>7aa4928325d0f6bca0fac16e8cbf4fcf</gtr:id><gtr:otherNames>Verra F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F5003CDA105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46F9D885-FA57-4267-9554-F355F355E1DF</gtr:id><gtr:title>Killer-cell immunoglobulin-like receptors and malaria caused by Plasmodium falciparum in The Gambia.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>pm_14853_23_22220719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D35CF1D4-1F88-4729-8147-C9CF6F2FD534</gtr:id><gtr:title>Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba809a63e6813d84c1775662d6bfcb7a"><gtr:id>ba809a63e6813d84c1775662d6bfcb7a</gtr:id><gtr:otherNames>Polley SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>C88B793022A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E280233-BD83-4482-A316-22F23C7F4523</gtr:id><gtr:title>Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/522e3401574cd4c13fb6eea59f5f9167"><gtr:id>522e3401574cd4c13fb6eea59f5f9167</gtr:id><gtr:otherNames>Osier FH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>BC17B3A3318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20C8C71D-65F2-4C63-B70E-CCD9CFBFA90D</gtr:id><gtr:title>RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.</gtr:title><gtr:parentPublicationTitle>PLoS clinical trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a4d265945497141c6417a2614ecfdb"><gtr:id>e5a4d265945497141c6417a2614ecfdb</gtr:id><gtr:otherNames>Enosse S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1555-5887</gtr:issn><gtr:outcomeId>D2851221BFC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AB006CE-8249-4375-8F39-C77806E9208F</gtr:id><gtr:title>Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens.</gtr:title><gtr:parentPublicationTitle>International journal for parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c65939e1c7043874ba79fecb123ce8cd"><gtr:id>c65939e1c7043874ba79fecb123ce8cd</gtr:id><gtr:otherNames>Weedall GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7519</gtr:issn><gtr:outcomeId>FE769024B94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68F6D860-2D2D-4E59-83D0-58D58AF08978</gtr:id><gtr:title>Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14853_23_23029157</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081993</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>